share_log

Riskified Analyst Ratings

Benzinga ·  Nov 16, 2023 04:32
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
11/16/2023 26.58% Piper Sandler → $5 Reiterates Overweight → Overweight
10/23/2023 26.58% Piper Sandler $7 → $5 Maintains Overweight
08/16/2023 89.87% Truist Securities → $7.5 Reiterates Buy → Buy
08/16/2023 77.22% Piper Sandler $8 → $7 Maintains Overweight
07/13/2023 39.24% Goldman Sachs $6 → $5.5 Maintains Neutral
05/18/2023 89.87% Credit Suisse $8 → $7.5 Maintains Outperform
05/17/2023 102.53% Piper Sandler → $8 Reiterates Overweight → Overweight
04/13/2023 39.24% Goldman Sachs $5 → $5.5 Maintains Neutral
03/10/2023 102.53% Piper Sandler $6 → $8 Upgrades Neutral → Overweight
02/24/2023 102.53% Credit Suisse $9 → $8 Maintains Outperform
02/24/2023 51.9% Piper Sandler → $6 Reiterates → Neutral
01/20/2023 Keybanc Downgrades Overweight → Sector Weight
01/09/2023 26.58% Goldman Sachs → $5 Upgrades Sell → Neutral
11/10/2022 26.58% Goldman Sachs $4.5 → $5 Maintains Sell
11/10/2022 127.85% Credit Suisse $8 → $9 Maintains Outperform
11/10/2022 26.58% Keybanc $6 → $5 Maintains Overweight
09/26/2022 51.9% Barclays $7 → $6 Maintains Overweight
08/11/2022 102.53% Credit Suisse $8.5 → $8 Maintains Outperform
08/11/2022 26.58% Goldman Sachs $4.5 → $5 Maintains Sell
08/11/2022 51.9% Piper Sandler $5 → $6 Maintains Neutral
07/18/2022 26.58% Piper Sandler $7 → $5 Maintains Neutral
07/14/2022 13.92% Goldman Sachs $6 → $4.5 Maintains Sell
07/07/2022 51.9% Keybanc $7 → $6 Maintains Overweight
05/23/2022 77.22% Barclays $8 → $7 Maintains Overweight
05/18/2022 153.16% Credit Suisse $12 → $10 Maintains Outperform
05/18/2022 77.22% Piper Sandler $10 → $7 Maintains Neutral
04/08/2022 64.56% Goldman Sachs $7 → $6.5 Maintains Sell
02/24/2022 203.8% Credit Suisse $18 → $12 Maintains Outperform
02/24/2022 153.16% Piper Sandler $14 → $10 Maintains Neutral
02/22/2022 254.43% Truist Securities $23 → $14 Maintains Buy
01/14/2022 153.16% Keybanc $18 → $10 Maintains Overweight
01/12/2022 254.43% Piper Sandler $17 → $14 Maintains Neutral
12/10/2021 127.85% Goldman Sachs → $9 Initiates Coverage On → Sell
11/17/2021 456.96% Credit Suisse $34 → $22 Maintains Outperform
11/02/2021 532.91% Keybanc $35 → $25 Maintains Overweight
08/23/2021 William Blair Initiates Coverage On → Outperform
08/23/2021 786.08% Truist Securities → $35 Initiates Coverage On → Buy
08/23/2021 735.44% Barclays → $33 Initiates Coverage On → Overweight
08/23/2021 634.18% JP Morgan → $29 Initiates Coverage On → Neutral
08/23/2021 735.44% Credit Suisse → $33 Initiates Coverage On → Outperform
08/23/2021 786.08% Keybanc → $35 Initiates Coverage On → Overweight
08/23/2021 710.13% Piper Sandler → $32 Initiates Coverage On → Overweight

What is the target price for Riskified (RSKD)?

The latest price target for Riskified (NYSE: RSKD) was reported by Piper Sandler on November 16, 2023. The analyst firm set a price target for $5.00 expecting RSKD to rise to within 12 months (a possible 26.58% upside). 13 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Riskified (RSKD)?

The latest analyst rating for Riskified (NYSE: RSKD) was provided by Piper Sandler, and Riskified reiterated their overweight rating.

When is the next analyst rating going to be posted or updated for Riskified (RSKD)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Riskified, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Riskified was filed on November 16, 2023 so you should expect the next rating to be made available sometime around November 16, 2024.

Is the Analyst Rating Riskified (RSKD) correct?

While ratings are subjective and will change, the latest Riskified (RSKD) rating was a reiterated with a price target of $0.00 to $5.00. The current price Riskified (RSKD) is trading at is $3.95, which is within the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment